Ecolab 1Q Sales Increase, Raises 2024 Adjusted EPS Outlook
By Denny Jacob
Ecolab posted an increase in 1Q sales while also raising its 2024 adjusted earnings per-share outlook.
The hygiene and infection-prevention company recorded net income of $412.1 million, or $1.43 a share, for the first quarter ended March 31, up from $233.4 million, or 82 cents a share, a year earlier. Adjusted earnings were $1.34 a share, matching analysts' estimates.
Sales rose 5% to $3.75 billion from $3.57 billion. Analysts polled by FactSet expected $3.74 billion.
For 2024, Ecolab forecast adjusted earnings per-share between $6.40 and $6.70. It previously guided for adjusted earnings per-share in the range of $6.10 and $6.50.
"We remain firmly on our long-term 12-15% earnings growth trajectory, with our exceptional growth in the first quarter the result of strong fundamentals and the additional benefit of lower delivered product costs," said Chief Executive Christophe Beck.
Ecolab also disclosed it reached a definitive agreement to sell its global surgical solutions business to Medline for a total consideration of $950 million cash, with an anticipated gain being recorded in special gains and charges at closing. The sale is expected to close in the second half of 2024.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 30, 2024 08:36 ET (12:36 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations